DK0806955T3 - Enrofloxacin-injektions- eller -infusionsoplösninger - Google Patents

Enrofloxacin-injektions- eller -infusionsoplösninger

Info

Publication number
DK0806955T3
DK0806955T3 DK95943218T DK95943218T DK0806955T3 DK 0806955 T3 DK0806955 T3 DK 0806955T3 DK 95943218 T DK95943218 T DK 95943218T DK 95943218 T DK95943218 T DK 95943218T DK 0806955 T3 DK0806955 T3 DK 0806955T3
Authority
DK
Denmark
Prior art keywords
infusion solutions
enrofloxacin injection
enrofloxacin
injection
infusion
Prior art date
Application number
DK95943218T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Bonse
Martin Hamm
Hanns-Peter Mueller
Arundev Haribhai Naik
Martin Scheer
Michael Stegemann
Oliver Vetter
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK0806955T3 publication Critical patent/DK0806955T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95943218T 1995-01-13 1995-12-28 Enrofloxacin-injektions- eller -infusionsoplösninger DK0806955T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19500784A DE19500784A1 (de) 1995-01-13 1995-01-13 Enrofloxacin-Injektions- oder Infusionslösungen

Publications (1)

Publication Number Publication Date
DK0806955T3 true DK0806955T3 (da) 2004-07-12

Family

ID=7751383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95943218T DK0806955T3 (da) 1995-01-13 1995-12-28 Enrofloxacin-injektions- eller -infusionsoplösninger

Country Status (28)

Country Link
US (1) US5998418A (fi)
EP (1) EP0806955B1 (fi)
JP (1) JP3835815B2 (fi)
CN (1) CN1125635C (fi)
AR (1) AR002265A1 (fi)
AT (1) ATE261731T1 (fi)
AU (1) AU695171B2 (fi)
BR (1) BR9510444A (fi)
CA (1) CA2210076C (fi)
CZ (1) CZ293934B6 (fi)
DE (2) DE19500784A1 (fi)
DK (1) DK0806955T3 (fi)
ES (1) ES2215183T3 (fi)
FI (1) FI119970B (fi)
HU (1) HU226826B1 (fi)
IL (1) IL116726A (fi)
JO (1) JO1883B1 (fi)
MX (1) MX9705266A (fi)
NO (1) NO313537B1 (fi)
NZ (1) NZ298778A (fi)
PL (1) PL182095B1 (fi)
PT (1) PT806955E (fi)
RU (1) RU2147225C1 (fi)
SK (1) SK284348B6 (fi)
TW (1) TW416852B (fi)
UA (1) UA42819C2 (fi)
WO (1) WO1996021453A1 (fi)
ZA (1) ZA96244B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
EP1827498A2 (de) * 2004-12-09 2007-09-05 Bayer HealthCare AG Stabilisierung von glucocorticoidestern mit säuren
CN100341510C (zh) * 2005-06-10 2007-10-10 冯莉萍 一种恩诺沙星微囊及制备方法
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
CN101230333B (zh) * 2007-01-26 2010-08-18 台湾尖端先进生技医药股份有限公司 恩罗氟沙星的单株抗体及其检测套组
US20100247687A1 (en) * 2009-03-30 2010-09-30 Mary Arnold-Ronish Formulation for tattoo removal and method of using same
CN101810569B (zh) * 2010-05-22 2011-09-21 鼎正动物药业（天津）有限公司 一种恩诺沙星注射液及其制备方法
CN103479569A (zh) * 2013-01-14 2014-01-01 四川喜亚动物药业有限公司 兽用环丙沙星注射液及其制备方法
RU2574007C2 (ru) * 2013-10-16 2016-01-27 Олег Иванович Киселев Инъекционный раствор для лечения вирусных заболеваний, выбранных из гриппа h1n1, h3n2, h5n1, клещевого энцефалита и лихорадки западного нила
US9993421B2 (en) * 2015-11-20 2018-06-12 Dynamo, Llc Method for treating deleterious effects arising from tattoos
CN107095848A (zh) * 2017-07-01 2017-08-29 山东中牧兽药有限公司 一种恩诺沙星注射液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
HU188181B (en) * 1981-06-11 1986-03-28 Warner-Lambert Co,Us Process for producing salts of naphtiridine and quinoline compounds of antimicrobial activity
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
SK94697A3 (en) 1997-11-05
CN1177300A (zh) 1998-03-25
BR9510444A (pt) 1998-05-19
CZ293934B6 (cs) 2004-08-18
JP3835815B2 (ja) 2006-10-18
UA42819C2 (uk) 2001-11-15
AU4434996A (en) 1996-07-31
CZ213097A3 (en) 1997-10-15
IL116726A0 (en) 1996-05-14
CA2210076C (en) 2007-12-18
IL116726A (en) 2000-07-16
TW416852B (en) 2001-01-01
RU2147225C1 (ru) 2000-04-10
AU695171B2 (en) 1998-08-06
DE59510878D1 (de) 2004-04-22
MX9705266A (es) 1997-10-31
PL182095B1 (pl) 2001-11-30
WO1996021453A1 (de) 1996-07-18
HU226826B1 (en) 2009-11-30
AR002265A1 (es) 1998-03-11
HUT77942A (hu) 1998-12-28
NO973223D0 (no) 1997-07-10
CN1125635C (zh) 2003-10-29
US5998418A (en) 1999-12-07
NO973223L (no) 1997-07-10
FI119970B (fi) 2009-05-29
DE19500784A1 (de) 1996-07-18
FI972966A (fi) 1997-07-11
NZ298778A (en) 1999-05-28
FI972966A0 (fi) 1997-07-11
ZA96244B (en) 1996-07-31
EP0806955B1 (de) 2004-03-17
SK284348B6 (sk) 2005-02-04
CA2210076A1 (en) 1996-07-18
PL321259A1 (en) 1997-11-24
NO313537B1 (no) 2002-10-21
JO1883B1 (en) 1996-07-25
ES2215183T3 (es) 2004-10-01
PT806955E (pt) 2004-06-30
ATE261731T1 (de) 2004-04-15
JPH10511967A (ja) 1998-11-17
EP0806955A1 (de) 1997-11-19

Similar Documents

Publication Publication Date Title
DE69627070D1 (de) Flüssigkeitseinspritzdüse
DK0963211T3 (da) Hypodermisk injektionssystem
DE69605402D1 (de) Infusionssystem
IS4646A (is) Stungunál fyrir gegnflæðiskerfi
DE69510024D1 (de) Spritze
DE69822160D1 (de) Verbesserte injektionsspritze
BR9304747A (pt) Injetor de medicamentos
DE69605168D1 (de) Einspritzventil
DE59510878D1 (de) Enrofloxacin-injektions- oder infusionslösungen
DE59507901D1 (de) Einspritzdüse
DE59502382D1 (de) Einspritzventil
DE69625992D1 (de) Einspritzventil
DE59602366D1 (de) Einspritzdüse
DE59606137D1 (de) Einspritzeinrichtung
FI972204A (fi) Suonensisäisiä lubelutsoliliuoksia
ATA153294A (de) Injektionsspritze
KR970020893U (ko) 주사용 바늘
SE9502763D0 (sv) Injektionssystem
KR970024138U (ko) 인젝터
KR960036443U (ko) 액체 분사장치
KR960034527U (ko) 액체류 주입기
IT1277106B1 (it) Strumento per agobiopsia coriale
KR950003078U (ko) 혈관주사보조기
KR970041527U (ko) 인젝션 펌프 연결구조
KR960036267U (ko) 세척기